PUBLISHER: Grand View Research | PRODUCT CODE: 2152685
PUBLISHER: Grand View Research | PRODUCT CODE: 2152685
The global endoscopic vessel harvesting system market size was valued at USD 164.8 million in 2025 and is projected to grow from USD 170.5 million in 2026 to USD 217.0 million in 2033, at a CAGR of 3.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% of revenue in 2025. The increasing prevalence of cardiovascular diseases globally, such as peripheral artery disease & coronary artery disease, and growing preference for minimally invasive harvesting procedures are key factors driving the market.
Cardiovascular diseases remain the leading cause of mortality worldwide. According to the estimates published by the World Health Organization (WHO) in July 2025, around 19.8 million people died from cardiovascular diseases in 2022, accounting for approximately 32% of all global deaths, with heart attacks and strokes representing the majority of these fatalities. The persistent burden of cardiovascular disorders continues to increase the demand for coronary artery bypass grafting (CABG) procedures and minimally invasive vessel harvesting technologies, thereby supporting the adoption of endoscopic vessel harvesting (EVH) systems.
In addition, the growing incidence of heart rhythm disorders, including atrial fibrillation (AFib), is driving the demand for innovative solutions, including EVH systems, to manage atherosclerosis and improve surgical outcomes. According to the American Heart Association (AHA), more than 5 million Americans currently live with atrial fibrillation, and this number is projected to exceed 12 million by 2030 due to population aging and increasing prevalence of risk factors such as hypertension, obesity, and diabetes. The increasing incidence of AFib and associated cardiovascular complications is expected to accelerate the demand for cardiac interventions and related harvesting technologies.
Furthermore, advancements in medical imaging technologies integrated into EVH devices have enabled surgeons to achieve improved visualization and procedural precision. Manufacturers are increasingly incorporating advanced imaging modalities, including near-infrared fluorescence imaging and high-definition endoscopic visualization technologies, into EVH systems to facilitate real-time vessel assessment, improve graft quality, and reduce the risk of vessel trauma during harvesting. These technological advancements contribute to improved outcomes in coronary artery bypass grafting procedures and are expected to support market growth over the forecast period.
Although advances in percutaneous coronary interventions have reduced the number of CABG procedures performed in certain patient populations, the growing adoption of endoscopic vessel harvesting (EVH) systems and the increasing preference for minimally invasive cardiac surgery continue to support market growth. EVH techniques reduce surgical trauma, lower the risk of wound complications, and promote faster postoperative recovery compared with conventional open vessel harvesting. Furthermore, evidence-based clinical recommendations and the continued emphasis on improving CABG outcomes are encouraging healthcare providers to adopt minimally invasive vessel-harvesting techniques, thereby supporting sustained demand for advanced EVH systems.
Moreover, the growing emphasis on evidence-based cardiac surgery practices continues to support the adoption of minimally invasive vessel harvesting techniques. The 2025 Clinical Practice Guideline, jointly issued by the Society of Thoracic Surgeons and the European Association for Cardio-Thoracic Surgery, reinforces recommendations for optimal conduit selection and harvesting techniques in coronary artery bypass grafting (CABG), highlighting strategies to improve graft quality, reduce postoperative complications, and enhance patient outcomes. These recommendations continue to encourage the adoption of endoscopic vessel harvesting systems in modern cardiac surgical practice.
Endoscopic Vessel Harvesting System Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global endoscopic vessel harvesting system market report based on product, application, and region:
Disposable
Re-usable
Coronary Artery Disease (CAD)
Peripheral Artery Disease (PAD)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa